RU2019113739A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2019113739A3 RU2019113739A3 RU2019113739A RU2019113739A RU2019113739A3 RU 2019113739 A3 RU2019113739 A3 RU 2019113739A3 RU 2019113739 A RU2019113739 A RU 2019113739A RU 2019113739 A RU2019113739 A RU 2019113739A RU 2019113739 A3 RU2019113739 A3 RU 2019113739A3
- Authority
- RU
- Russia
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H4/00—Plant reproduction by tissue culture techniques ; Tissue culture techniques therefor
- A01H4/001—Culture apparatus for tissue culture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0025—Culture media for plant cell or plant tissue culture
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Reproductive Health (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Analytical Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102016000101870A IT201600101870A1 (it) | 2016-10-11 | 2016-10-11 | Ligandi del recettore dell’ormone FSH nella diagnosi e nella terapia del neuroblastoma |
IT102016000101862A IT201600101862A1 (it) | 2016-10-11 | 2016-10-11 | Ligandi del recettore dell’ormone FSH nella diagnosi e nella terapia dei tumori |
IT102016000101852A IT201600101852A1 (it) | 2016-10-11 | 2016-10-11 | Ligandi del recettore dell’ormone FSH nella diagnosi e nella terapia dei tumori |
IT102016000101852 | 2016-10-11 | ||
IT102016000101862 | 2016-10-11 | ||
IT102016000101870 | 2016-10-11 | ||
PCT/IB2017/056251 WO2018069831A2 (en) | 2016-10-11 | 2017-10-10 | Ligands of the fsh hormone receptor in the diagnosis and treatment of tumors |
Publications (3)
Publication Number | Publication Date |
---|---|
RU2019113739A RU2019113739A (ru) | 2020-11-13 |
RU2019113739A3 true RU2019113739A3 (ru) | 2021-01-25 |
RU2755000C2 RU2755000C2 (ru) | 2021-09-08 |
Family
ID=60382478
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2019113739A RU2755000C2 (ru) | 2016-10-11 | 2017-10-10 | Лиганды к рецептору фолликулостимулирующего гормона (FSH) в диагностике и лечении опухолей |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP3525810A2 (ru) |
JP (1) | JP7226803B2 (ru) |
KR (1) | KR102636093B1 (ru) |
CN (1) | CN110072542A (ru) |
CA (1) | CA3039762A1 (ru) |
IL (1) | IL265889A (ru) |
RU (1) | RU2755000C2 (ru) |
WO (1) | WO2018069831A2 (ru) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2755000C2 (ru) * | 2016-10-11 | 2021-09-08 | Онкогреен Тхерапеутикс Са | Лиганды к рецептору фолликулостимулирующего гормона (FSH) в диагностике и лечении опухолей |
KR20230117390A (ko) * | 2020-12-04 | 2023-08-08 | 캔웰 (지제트) 바이오테크 리미티드 | 항-fshr 항체 및 이의 항체-약물 접합체의 제조 및용도 |
WO2023012281A1 (en) | 2021-08-04 | 2023-02-09 | Fshr Theranostics | Use of fsh-receptor ligands for diagnosis and therapy of atherosclerosis |
WO2024100548A1 (en) * | 2022-11-08 | 2024-05-16 | Oncogreen Therapeutics S.A. | Compound with anti-metastatic effect |
WO2024100549A1 (en) * | 2022-11-08 | 2024-05-16 | Oncogreen Therapeutics S.A. | Compounds for use in macrophage reprogramming |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1206302B (it) * | 1987-06-26 | 1989-04-14 | Serono Cesare Ist Ricerca | Ormone follicolo-stimolante urinario |
EP2090322A1 (en) * | 2008-02-18 | 2009-08-19 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of fsh receptor ligands for diagnosis and therapy of cancer |
EP2920212A4 (en) * | 2012-11-15 | 2016-07-27 | Esperance Pharmaceuticals Inc | FUSION CONSTRUCTS FROM FOLLICULAR STIMULATING HORMONE (FSH) AND A LYTIC DOMAIN AND METHOD FOR THE PRODUCTION AND USE THEREOF |
CN103509121B (zh) * | 2012-11-22 | 2015-01-28 | 苏州康宁杰瑞生物科技有限公司 | 一种fsh融合蛋白及其制备方法和用途 |
LT3200815T (lt) * | 2014-10-02 | 2021-07-26 | The Wistar Institute Of Anatomy And Biology | Būdai ir kompozicijos, skirti vėžio gydymui |
RU2755000C2 (ru) * | 2016-10-11 | 2021-09-08 | Онкогреен Тхерапеутикс Са | Лиганды к рецептору фолликулостимулирующего гормона (FSH) в диагностике и лечении опухолей |
-
2017
- 2017-10-10 RU RU2019113739A patent/RU2755000C2/ru active
- 2017-10-10 CN CN201780076373.9A patent/CN110072542A/zh active Pending
- 2017-10-10 WO PCT/IB2017/056251 patent/WO2018069831A2/en active Search and Examination
- 2017-10-10 EP EP17800599.7A patent/EP3525810A2/en active Pending
- 2017-10-10 JP JP2019540719A patent/JP7226803B2/ja active Active
- 2017-10-10 CA CA3039762A patent/CA3039762A1/en active Pending
- 2017-10-10 KR KR1020197012320A patent/KR102636093B1/ko active IP Right Grant
-
2019
- 2019-04-07 IL IL265889A patent/IL265889A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN110072542A (zh) | 2019-07-30 |
KR20190065331A (ko) | 2019-06-11 |
IL265889A (en) | 2019-06-30 |
EP3525810A2 (en) | 2019-08-21 |
RU2755000C2 (ru) | 2021-09-08 |
JP7226803B2 (ja) | 2023-02-21 |
WO2018069831A2 (en) | 2018-04-19 |
RU2019113739A (ru) | 2020-11-13 |
JP2020501599A (ja) | 2020-01-23 |
CA3039762A1 (en) | 2018-04-19 |
WO2018069831A3 (en) | 2018-07-12 |
KR102636093B1 (ko) | 2024-02-13 |